Stanford's Agentic AI 'Scientists' Poised to Transform Drug Discovery at VB Transform 2026
Stanford researchers have developed thousands of autonomous AI agents that simulate the full drug discovery process, aiming to overcome high failure rates and inefficiencies in pharmaceutical development. These agentic scientists maintain project continuity from discovery to clinical trials, leveraging extensive data and a hierarchical orchestration system. Insights on managing complex AI workflows and data integration will be shared at VB Transform 2026.
Former Palantir Executive Launches NHS-Focused AI Startup with £9.7M Funding
A London-based startup founded by a former Palantir healthcare executive, who worked in NHS hospitals during Covid, has raised £9.7 million in funding to advance its AI solutions for the NHS. The funding round was led by At..., aiming to innovate healthcare with cutting-edge technology.
Groundbreaking Study Highlights AMIE AI's Role in Complex Disease Management
New research in the journal "Nature" demonstrates that AMIE, a conversational AI, matches the performance of primary care physicians in managing complex diseases, highlighting its potential to assist in healthcare management.
Addressing AI's Increasing Energy Demand: A Public Health Concern
Sten H. Vermund and Patricia J. Kissinger discuss how AI's rising energy demands pose significant risks to public health. They call for awareness and solutions to reduce AI's environmental and health impacts.
From Setback to Smart Solution: How a Biotech Startup Created an AI Model from a Failed Trial
A biotech startup turned a failed clinical trial into an innovative AI model, showcasing resilience and ingenuity in healthcare technology. This transformation highlights the potential of AI in advancing medical research despite setbacks.
Exploring Breakthroughs in Obesity Medications and the Rise of Peptide Therapies
This article examines the latest developments in obesity medications, highlights a company that achieved a record IPO, and discusses upcoming FDA decisions on new treatments, emphasizing the growing role of peptide therapies in mainstream medicine.
Analysis Reveals Persistent Systemic Issues in U.S. Prescription Drug Shortages Despite Recent Decline
A recent analysis shows that while U.S. prescription drug shortages dropped by nearly a quarter last year, systemic issues continue to impact the consistent supply of essential medicines.
Wearable Health Devices Are Poised to Enter Clinical Care with New Data Innovations
Wearable health devices like Oura and Whoop are beginning to bring the health data they generate into clinical care. This shift could transform how patient health is monitored by integrating real-time data from wearables into medical settings, improving health insights and treatment outcomes.
Life Biosciences Begins Human Trials of Groundbreaking Vision and Aging Therapy
Life Biosciences has initiated human trials for a novel therapy aimed at reversing vision loss and cellular aging. The first patient has been dosed, underscoring progress in pioneering treatments that could transform age-related health conditions.
Doctors and NHS Face Legal Risks Over AI Diagnostic Errors, Report Highlights
A new report warns that doctors and the NHS could be held legally responsible for errors made by AI diagnostic and treatment tools. The Medical Protection Society calls for legal reforms to ensure healthcare professionals are not unfairly liable for AI-driven mistakes as technology increasingly supports medical decisions.
China Approves World's First Commercial Brain-Computer Interface, Advancing Beyond Neuralink
China has become the first country to approve a commercial brain-computer interface, NEO, which enables patients with spinal cord injuries to control machines using their minds. Developed by NeuraMatrix and Tsinghua University, this innovation moves brain-machine technology beyond theory into practical medical use, signaling a new era in neural technology.
Can AI-Driven Digital Twins Revolutionize Heart Care for Women?
Sumesh Sasidharan discusses the potential and challenges of AI digital twins in heart care, highlighting concerns about whether these innovations will address women's specific medical needs effectively, pointing to disparities in healthcare technology benefits.
Financing Models Needed for Multi-Million Dollar Gene Therapy Treatments
Gene therapies costing millions are available, but the healthcare system lacks the necessary financing and delivery infrastructure to make these cures accessible, according to William Padula.
NewLimit Raises $435 Million to Develop Cellular Aging Reversal Therapy
NewLimit, a biotech startup, has secured $435 million in funding to develop a novel medicine that reverses cellular aging in the liver, marking a significant advance in longevity research.
Reid Hoffman Exits Microsoft Board to Lead AI-Driven Drug Startup Manus
Reid Hoffman is leaving Microsoft’s board after nearly a decade to focus on Manus, his AI-driven drug discovery startup. Having joined the board post-LinkedIn acquisition in 2016, Hoffman is shifting attention to innovation in healthcare through AI technology.
Introducing AI-Powered Ambient Scribes for Patient Use in Doctor’s Offices
AI-driven ambient scribes, initially used in hospitals, are now being adapted to help patients by taking notes during doctor appointments, improving the accuracy of medical records and easing the consultation experience.
Insights from the First Randomized Trial of Multi-Cancer Early Detection: An Oncologist’s Perspective
An oncologist discusses three important lessons learned from the world's first randomized trial on multi-cancer early detection. While the Grail trial's results were negative, the expert emphasizes valuable insights and future potential for cancer screening advancements.
Understanding the Pope’s Encyclical on AI: Implications for Catholic Hospitals and the Broader Healthcare Sector
Brittany Trang delves into the pope's encyclical on AI in STAT's AI Prognosis, unpacking its important messages and potential impact on Catholic hospitals and healthcare as a whole.
Opinion: Navigating the AI Battle in Medical Billing Between Providers and Insurers
Darshak Sanghavi discusses how the escalating use of AI in medical billing is transforming financial challenges into clinical issues, affecting patient care as providers and insurers engage in a high-stakes competition over costs and reimbursements.
Anthropic Expands Claude Mythos Security Program to Safeguard Critical Infrastructure Across 15+ Countries
Anthropic extends its security program and Mythos platform to 150 organizations in 15+ countries, targeting critical sectors like power, water, healthcare, and communications to protect against cyber threats impacting 100 million individuals.